X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/02/2874013/33130/en/ADMA-Biologics-to-Report-First-Quarter-2024-Financial-Results-on-May-9-2024.html
https://www.globenewswire.com//news-release/2024/03/11/2843606/33130/en/ADMA-Biologics-Announces-FDA-Approvals-of-Extended-Room-Temperature-Storage-Conditions-for-ASCENIV-BIVIGAM.html
https://www.globenewswire.com//news-release/2024/03/05/2840284/33130/en/ADMA-Biologics-to-Participate-in-the-Raymond-James-Institutional-Investor-Conference.html
https://www.globenewswire.com//news-release/2024/02/28/2837444/33130/en/ADMA-Biologics-Announces-CFO-Transition.html
https://www.globenewswire.com//news-release/2024/02/28/2837428/33130/en/ADMA-Biologics-Announces-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2024/02/21/2833113/33130/en/ADMA-Biologics-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-February-28-2024.html
https://www.globenewswire.com//news-release/2024/02/21/2832624/33130/en/ADMA-Biologics-Successfully-Implements-Innovative-AI-Program-Named-ADMAlytics.html
https://www.globenewswire.com//news-release/2024/01/08/2805282/33130/en/ADMA-Biologics-Announces-Preliminary-Fourth-Quarter-2023-Revenue-and-Provides-Business-Update.html
https://www.globenewswire.com//news-release/2023/12/18/2798134/33130/en/ADMA-Biologics-Announces-135-Million-Non-Dilutive-Refinancing-of-Credit-Facilities-with-Ares-Management.html
https://www.globenewswire.com//news-release/2023/12/12/2794607/33130/en/ADMA-Biologics-Announces-FDA-Approval-for-BIVIGAM-in-the-Pediatric-Patient-Setting-for-Those-2-Years-of-Age-and-Older.html
Market Place
Share 
